Cargando…

Current status of PET imaging in Huntington’s disease

PURPOSE: To review the developments of recent decades and the current status of PET molecular imaging in Huntington’s disease (HD). METHODS: A systematic review of PET studies in HD was performed. The MEDLINE, Web of Science, Cochrane and Scopus databases were searched for articles in all languages...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pagano, Gennaro, Niccolini, Flavia, Politis, Marios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844650/ https://www.ncbi.nlm.nih.gov/pubmed/26899245 http://dx.doi.org/10.1007/s00259-016-3324-6

Ejemplares similares

The serotonergic system in Parkinson’s patients with dyskinesia: evidence from imaging studies
por: Pagano, Gennaro, et al.
Publicado: (2017)

Cholinergic imaging in dementia spectrum disorders
por: Roy, Roman, et al.
Publicado: (2016)

Molecular Imaging Markers to Track Huntington’s Disease Pathology
por: Wilson, Heather, et al.
Publicado: (2017)

A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism
por: Niccolini, Flavia, et al.
Publicado: (2016)

Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)
por: Yousaf, Tayyabah, et al.
Publicado: (2019)

PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Pagano, Gennaro, et al.
Publicado: (2017)

Dysphagia is associated with presynaptic dopaminergic dysfunction and greater non-motor symptom burden in early drug-naïve Parkinson’s patients
por: Polychronis, Sotirios, et al.
Publicado: (2019)

Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson’s disease
por: Niccolini, Flavia, et al.
Publicado: (2019)

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
por: Chandra, Avinash, et al.
Publicado: (2019)

Dementia spectrum disorders: lessons learnt from decades with PET research
por: Wilson, Heather, et al.
Publicado: (2019)

Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
por: Wilson, Heather, et al.
Publicado: (2019)

Correction to: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
por: Wilson, Heather, et al.
Publicado: (2022)

PET Imaging in Huntington’s Disease
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2015)

Huntington’s Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers
por: Cybulska, Klaudia, et al.
Publicado: (2020)

Huntington's disease: Molecular basis of pathology and status of current therapeutic approaches
por: Huang, Wen-Juan, et al.
Publicado: (2016)

Current status of PET imaging in neuro-oncology
por: Galldiks, Norbert, et al.
Publicado: (2019)

Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases
por: Wilson, Heather, et al.
Publicado: (2020)

Neuroimaging of Sleep Disturbances in Movement Disorders
por: Yousaf, Tayyabah, et al.
Publicado: (2018)

[(18)F]Florbetapir PET/MR imaging to assess demyelination in multiple sclerosis
por: Carotenuto, Antonio, et al.
Publicado: (2019)

Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s disease
por: Schulz, Jonathan, et al.
Publicado: (2018)

A Critical Evaluation of Wet Biomarkers for Huntington’s Disease: Current Status and Ways Forward
por: Silajdžić, Edina, et al.
Publicado: (2018)

Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment
por: Chandra, Avinash, et al.
Publicado: (2018)

Disease-related patterns of in vivo pathology in Corticobasal syndrome
por: Niccolini, Flavia, et al.
Publicado: (2018)

The Current Status of Neural Grafting in the Treatment of Huntington’s Disease. A Review
por: Wijeyekoon, Ruwani, et al.
Publicado: (2011)

Exercise in Huntington’s Disease: Current State and Clinical Significance
por: Mueller, Sandro Manuel, et al.
Publicado: (2019)

Current and Possible Future Therapeutic Options for Huntington’s Disease
por: Ferguson, Mackenzie W., et al.
Publicado: (2022)

Current Pharmacological Approaches to Reduce Chorea in Huntington’s Disease
por: Coppen, Emma M., et al.
Publicado: (2016)

Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease
por: Politis, Marios
Publicado: (2011)

PET Oncological Radiopharmaceuticals: Current Status and Perspectives
por: Lin, Mai, et al.
Publicado: (2022)

PET/MR imaging: current status and future direction
por: Schlemmer, Heinz-Peter
Publicado: (2015)

Investigating the Transition of Pre-Symptomatic to Symptomatic Huntington’s Disease Status Based on Omics Data
por: Christodoulou, Christiana C., et al.
Publicado: (2020)

Current Status of Huntington’s Disease in Korea: A Nationwide Survey and National Registry Analysis
por: Kim, Hyun Sook, et al.
Publicado: (2015)

Sleep Dysfunction in Huntington’s Disease: Impacts of Current Medications and Prospects for Treatment
por: Owen, Natalia E., et al.
Publicado: (2023)

Serotonergic Dysfunction in Parkinson's Disease and Its Relevance to Disability
por: Politis, Marios, et al.
Publicado: (2011)

PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions
por: Unterrainer, Marcus, et al.
Publicado: (2020)

Current Pharmacological Management in Juvenile Huntington’s Disease
por: Robertson, Lisa, et al.
Publicado: (2012)

Irritability in Huntington’s Disease
por: Karagas, Nicholas E., et al.
Publicado: (2020)

Current Diagnostic Methods and Non-Coding RNAs as Possible Biomarkers in Huntington’s Disease
por: Pellegrini, Miguel, et al.
Publicado: (2022)

Current Perspectives on (89)Zr-PET Imaging
por: Yoon, Joon-Kee, et al.
Publicado: (2020)

Current and Future PET Imaging for Multiple Myeloma
por: Ishibashi, Mariko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cb21kfepb0r15goorhcesuculh